Because the PI3K/AKT and AMPK/mTOR signaling pathways are classical pathways involved in energy metabolism, we next analyzed tumor samples from the TCGA database and found that patients with high expression of ENO1 (a key enzyme in glycolysis) presented higher glycolysis-related scores (Supplementary Fig. 6a). Here, AKT1 is linked to neoplasm.